Mutant FUS induces chromatin reorganization in the hippocampus and alters memory processes

[1]  V. Orlando,et al.  Behind the scenes: How RNA orchestrates the epigenetic regulation of gene expression , 2023, Frontiers in Cell and Developmental Biology.

[2]  Wei Li,et al.  Enhancer RNA: What we know and what we can achieve , 2022, Cell proliferation.

[3]  Nicolas L. Fawzi,et al.  Molecular interactions contributing to FUS SYGQ LC-RGG phase separation and co-partitioning with RNA polymerase II heptads , 2021, Nature Structural & Molecular Biology.

[4]  Michael J. Bolt,et al.  Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. , 2021, Molecular cell.

[5]  Mahdi Muhammad Moosa,et al.  FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion‐like domains , 2021, Protein science : a publication of the Protein Society.

[6]  Katharina M. Hembach,et al.  Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects , 2021, Nature Communications.

[7]  R. Kehlenbach,et al.  The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors , 2021, The Journal of biological chemistry.

[8]  Pilong Li,et al.  Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription , 2021, Nature Communications.

[9]  D. Cleveland,et al.  Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation , 2020, bioRxiv.

[10]  Hong Zhang,et al.  Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases , 2020, International journal of molecular sciences.

[11]  Sylvain Egloff,et al.  Noncoding RNAs Set the Stage for RNA Polymerase II Transcription. , 2020, Trends in genetics : TIG.

[12]  Manolis Kellis,et al.  Mapping the epigenomic and transcriptomic interplay during memory formation and recall in the hippocampal engram ensemble , 2020, Nature Neuroscience.

[13]  Gary L. Pattee,et al.  Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. , 2020, The New England journal of medicine.

[14]  Anna L. Brown,et al.  FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention , 2020, Nucleic acids research.

[15]  Julie L. Winterburn,et al.  Structural Variant in Mitochondrial-Associated Gene (MRPL3) Induces Adult-Onset Neurodegeneration with Memory Impairment in the Mouse , 2020, The Journal of Neuroscience.

[16]  L. Dupuis,et al.  Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases , 2020, Cell stress.

[17]  J. Veldink,et al.  Chorea is a pleiotropic clinical feature of mutated fused-in-sarcoma in amyotrophic lateral sclerosis , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[18]  P. Wong,et al.  FUS-mediated dysregulation of Sema5a, an autism-related gene, in FUS mice with hippocampus-dependent cognitive deficits. , 2019, Human molecular genetics.

[19]  O. Mühlemann,et al.  The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid–liquid phase separation , 2019, bioRxiv.

[20]  Satoshi O. Suzuki,et al.  Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)‐binding protein 1 in Huntington's disease , 2019, Neuropathology : official journal of the Japanese Society of Neuropathology.

[21]  V. Corces,et al.  Immediate and deferred epigenomic signatures of in vivo neuronal activation in mouse hippocampus , 2019, Nature Neuroscience.

[22]  T. Boeckers,et al.  FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis , 2019, Nature Neuroscience.

[23]  J. Ule,et al.  Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis , 2019, Brain : a journal of neurology.

[24]  Mariana P. Torrente,et al.  The impact of histone post-translational modifications in neurodegenerative diseases. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[25]  A. Ståhlberg,et al.  FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex , 2019, EMBO reports.

[26]  Y. Dou,et al.  Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation , 2019, bioRxiv.

[27]  M. Wood,et al.  How the epigenome integrates information and reshapes the synapse , 2019, Nature Reviews Neuroscience.

[28]  C. Greer,et al.  Histone H3 lysine K4 methylation and its role in learning and memory , 2019, Epigenetics & Chromatin.

[29]  V. F. Thompson,et al.  Transcription-Dependent Formation of Nuclear Granules Containing FUS and RNA Pol II. , 2018, Biochemistry.

[30]  P. Dutar,et al.  Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator , 2018, EMBO molecular medicine.

[31]  Michael E. Greenberg,et al.  Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior , 2018, Neuron.

[32]  Kirsten A. Porter-Stransky,et al.  LSD1 protects against hippocampal and cortical neurodegeneration , 2017, Nature Communications.

[33]  B. Burke,et al.  Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in ‘FUSDelta14’ knockin mice , 2017, Brain : a journal of neurology.

[34]  Yang Shi,et al.  Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons. , 2017, Cell reports.

[35]  A. F. Stewart,et al.  KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. , 2017, Cell reports.

[36]  Ying Sun,et al.  Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis , 2017, Acta Neuropathologica.

[37]  H. Okano,et al.  Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes. , 2017, Cell reports.

[38]  Peter C. Hollenhorst,et al.  An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer. , 2016, Cell reports.

[39]  G. Sobue,et al.  FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice , 2016, Scientific Reports.

[40]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[41]  Xiang-Dong Fu,et al.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss , 2016, The EMBO journal.

[42]  Andrew Thompson,et al.  A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone Methylation. , 2016, Cell reports.

[43]  J. Tapia,et al.  ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function , 2016, Nature Communications.

[44]  Nicolas L. Fawzi,et al.  Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. , 2015, Molecular cell.

[45]  Cory B. Giles,et al.  Detrimental effects of duplicate reads and low complexity regions on RNA- and ChIP-seq data , 2015, BMC Bioinformatics.

[46]  M. Mesulam,et al.  FUS Interacts with HSP60 to Promote Mitochondrial Damage , 2015, PLoS genetics.

[47]  C. Dickson,et al.  Intrahippocampal Anisomycin Impairs Spatial Performance on the Morris Water Maze , 2015, The Journal of Neuroscience.

[48]  G. Sobue,et al.  FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization , 2015, Nature Communications.

[49]  T. Hashikawa,et al.  FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis , 2015, Acta neuropathologica communications.

[50]  M. Strong,et al.  Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. , 2015, Human molecular genetics.

[51]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[52]  Jing Chen,et al.  Self-assembled FUS binds active chromatin and regulates gene transcription , 2014, Proceedings of the National Academy of Sciences.

[53]  D. A. Bosco,et al.  A loss of FUS/TLS function leads to impaired cellular proliferation , 2014, Cell Death and Disease.

[54]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[55]  Ananya Chowdhury,et al.  Synapse rearrangements upon learning: from divergent–sparse connectivity to dedicated sub-circuits , 2014, Trends in Neurosciences.

[56]  K. Eggan,et al.  FUS is sequestered in nuclear aggregates in ALS patient fibroblasts , 2014, Molecular biology of the cell.

[57]  L. Dugué,et al.  Anisomycin injection in area CA3 of the hippocampus impairs both short-term and long-term memories of contextual fear , 2014, Learning & memory.

[58]  Daniel R. Zerbino,et al.  WiggleTools: parallel processing of large collections of genome-wide datasets for visualization and statistical analysis , 2013, Bioinform..

[59]  Li-Huei Tsai,et al.  Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons , 2013, Nature Neuroscience.

[60]  T. Cech,et al.  FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. , 2012, Genes & development.

[61]  Stephanie C Huelga,et al.  Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs , 2012, Nature Neuroscience.

[62]  G. Rouleau,et al.  Exome sequencing identifies FUS mutations as a cause of essential tremor. , 2012, American journal of human genetics.

[63]  J. Grafman,et al.  FUS and TDP43 genetic variability in FTD and CBS , 2012, Neurobiology of Aging.

[64]  D. Neary,et al.  Pathological correlates of frontotemporal lobar degeneration in the elderly , 2011, Acta Neuropathologica.

[65]  C. Duyckaerts,et al.  Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID) , 2011, Journal of Neural Transmission.

[66]  D. Neary,et al.  The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene , 2011, Acta Neuropathologica.

[67]  C. Duyckaerts,et al.  The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease , 2011, Acta Neuropathologica.

[68]  N. Cairns,et al.  Distinct pathological subtypes of FTLD-FUS , 2011, Acta Neuropathologica.

[69]  J. Caboche,et al.  Elk-1 a Transcription Factor with Multiple Facets in the Brain , 2011, Front. Neurosci..

[70]  Tao Ye,et al.  seqMINER: an integrated ChIP-seq data interpretation platform , 2010, Nucleic acids research.

[71]  W. Engel,et al.  Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia , 2010, Neurology.

[72]  J. Lowe,et al.  Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations , 2010, Neurology.

[73]  R. Petersen,et al.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration , 2010, Acta Neuropathologica.

[74]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[75]  K. Sleegers,et al.  Genetic contribution of FUS to frontotemporal lobar degeneration , 2010, Neurology.

[76]  Y. Kuroiwa,et al.  The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases , 2010, Neuroscience Research.

[77]  Ira M. Hall,et al.  BEDTools: a flexible suite of utilities for comparing genomic features , 2010, Bioinform..

[78]  J. Manley,et al.  TLS Inhibits RNA Polymerase III Transcription , 2009, Molecular and Cellular Biology.

[79]  Chen Zeng,et al.  A clustering approach for identification of enriched domains from histone modification ChIP-Seq data , 2009, Bioinform..

[80]  Hélène Marie,et al.  Viral‐mediated expression of a constitutively active form of CREB in hippocampal neurons increases memory , 2009, Hippocampus.

[81]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[82]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[83]  C. Glass,et al.  Induced ncRNAs Allosterically Modify RNA Binding Proteins in cis to Inhibit Transcription , 2008, Nature.

[84]  Richard A Young,et al.  Global and Hox-specific roles for the MLL1 methyltransferase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Hicks,et al.  The RNA Binding Protein TLS Is Translocated to Dendritic Spines by mGluR5 Activation and Regulates Spine Morphology , 2005, Current Biology.

[86]  D. Ron,et al.  Human 75-kDa DNA-pairing Protein Is Identical to the Pro-oncoprotein TLS/FUS and Is Able to Promote D-loop Formation* , 1999, The Journal of Biological Chemistry.

[87]  KM Harris,et al.  Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents] , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[88]  E. Kandel,et al.  The regulation of transcription in memory consolidation. , 2014, Cold Spring Harbor perspectives in biology.

[89]  Weiqun Peng,et al.  Spatial clustering for identification of ChIP-enriched regions (SICER) to map regions of histone methylation patterns in embryonic stem cells. , 2014, Methods in molecular biology.

[90]  S. Richard,et al.  Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. , 2012, Human molecular genetics.

[91]  B M Raaka,et al.  TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. , 1998, Molecular endocrinology.